Table 2.
BRCA1 (n = 1,847 pairs) | P | BRCA2 (n = 714 pairs) | P | |
---|---|---|---|---|
OR (95%CI) | OR (95%CI) | |||
Age at menarche (years)1 | ||||
≤ 11 | 1.00 (reference) | 1.00 (reference) | ||
12 | 0.66 (0.52–0.84) | 0.0005 | 0.85(0.61–1.20) | 0.36 |
13 | 0.74 (0.59–0.92) | 0.007 | 0.84(0.60–1.16) | 0.28 |
14 | 0.65 (0.51–0.84) | 0.0002 | 0.98(0.65–1.46) | 0.90 |
≥ 15 | 0.58 (0.45–0.74) | <0.0001 | 1.27(0.82–1.96) | 0.28 |
Trend | 0.91 (0.86–0.96) | <0.0001 | 1.05(0.96–1.15) | 0.28 |
Parity (per birth)2 | ||||
Nulliparous | 1.00 (reference) | 1.00 (reference) | ||
1 | 1.36 (1.03–1.80) | 0.03 | 1.57 (1.03–2.40) | 0.04 |
2 | 1.39 (1.07–1.82) | 0.01 | 1.46 (1.00–2.14) | 0.05 |
3 | 1.44 (1.06–1.95) | 0.02 | 1.45 (0.94–2.22) | 0.09 |
≥ 4 | 1.19 (0.82–1.74) | 0.37 | 0.94 (0.53–1.67) | 0.84 |
Trend | 1.07 (0.99–1.15) | 0.11 | 1.04 (0.93–1.16) | 0.49 |
Breastfeeding (years)3 | ||||
0 | 1.00 (reference) | 1.00 (reference) | ||
≤ 1 | 0.81 (0.66–1.00) | 0.05 | 1.03 (0.76–1.40) | 0.85 |
1 – ≤ 2 | 0.65 (0.50–0.85) | 0.001 | 1.04 (0.70–1.53) | 0.86 |
2 – ≤ 3 | 0.51 (0.35–0.75) | 0.0006 | 1.33 (0.76–2.32) | 0.31 |
> 3 | 0.45 (0.30–0.68) | 0.0002 | 1.02 (0.56–1.88) | 0.94 |
Trend | 0.82 (0.75–0.89) | <0.0001 | 1.01 (0.95–1.08) | 0.68 |
OC use (years)4 | ||||
0 | 1.00 (reference) | 1.00 (reference) | ||
≤ 1 | 1.15 (0.90–1.47) | 0.27 | 1.01 (0.71–1.46) | 0.93 |
1 – ≤ 2 | 0.89 (0.65–1.22) | 0.47 | 1.15 (0.72–1.84) | 0.56 |
2 – ≤ 3 | 0.92 (0.66–1.27) | 0.60 | 0.90 (0.55–1.46) | 0.66 |
> 3 | 1.10 (0.82–1.34) | 0.32 | 1.03 (0.77–1.37) | 0.86 |
Trend | 1.02 (0.97–1.07) | 0.45 | 1.04 (0.92–1.17) | 0.54 |
Only includes women who had no missing data for age at menarche (n = 2,561).
Estimate adjusted for parity, breastfeeding and oral contraceptive use.
Estimate adjusted for age at menarche, breastfeeding and oral contraceptive use.
Estimate adjusted for age at menarche, parity and oral contraceptive use.
Estimate adjusted for age at menarche, breastfeeding and parity.